Allergan buys gene therapy play RetroSense

Allergan plc (NYSE:AGN) acquired RetroSense Therapeutics LLC (Ann Arbor, Mich.), giving it retinitis pigmentosa (RP) candidate RST-001.

Read the full 172 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE